Fredlund E, Andersson S, Hilgert E, Monferrer E, Alvarez-Hernan G, Karakaya S
Sci Adv. 2024; 10(25):eado1583.
PMID: 38905335
PMC: 11192077.
DOI: 10.1126/sciadv.ado1583.
Sehgal M, Nayak S, Sahoo S, Somarelli J, Jolly M
Cancer Biol Ther. 2024; 25(1):2301802.
PMID: 38230570
PMC: 10795782.
DOI: 10.1080/15384047.2024.2301802.
DAmico S, Tempora P, Gragera P, Krol K, Melaiu O, De Ioris M
Front Immunol. 2023; 14:1268645.
PMID: 37849756
PMC: 10577183.
DOI: 10.3389/fimmu.2023.1268645.
Thirant C, Peltier A, Durand S, Kramdi A, Louis-Brennetot C, Pierre-Eugene C
Nat Commun. 2023; 14(1):2575.
PMID: 37142597
PMC: 10160107.
DOI: 10.1038/s41467-023-38239-5.
Horwacik I
Cells. 2022; 11(19).
PMID: 36231134
PMC: 9564247.
DOI: 10.3390/cells11193172.
BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells.
Sriha J, Louis-Brennetot C, Pierre-Eugene C, Baulande S, Raynal V, Kramdi A
Cancers (Basel). 2022; 14(11).
PMID: 35681734
PMC: 9179499.
DOI: 10.3390/cancers14112755.
Recent advances in the developmental origin of neuroblastoma: an overview.
Ponzoni M, Bachetti T, Corrias M, Brignole C, Pastorino F, Calarco E
J Exp Clin Cancer Res. 2022; 41(1):92.
PMID: 35277192
PMC: 8915499.
DOI: 10.1186/s13046-022-02281-w.
A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma.
Perri P, Ponzoni M, Corrias M, Ceccherini I, Candiani S, Bachetti T
Cancers (Basel). 2021; 13(21).
PMID: 34771690
PMC: 8582685.
DOI: 10.3390/cancers13215528.
Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT).
Gautier M, Thirant C, Delattre O, Janoueix-Lerosey I
Cancers (Basel). 2021; 13(12).
PMID: 34200747
PMC: 8230375.
DOI: 10.3390/cancers13122904.
